Glaxosmithkline

This study tested a new medicine called GSK3915393 for people with idiopathic pulmonary fibrosis (IPF), a chronic lung disease that causes scarring and breathing difficulty. The trial aimed to see if the drug could slow lung function decline, but it was terminated early. About 15…

This study tested an experimental drug called GSK1070806 for adults with moderate to severe atopic dermatitis (eczema) who had already tried other treatments. The goal was to see if the drug could reduce eczema severity and itching. The study was stopped early, so final results a…

This study tested a new therapeutic vaccine (GSK3528869A) in adults aged 18-65 with chronic hepatitis B whose virus was already well-controlled by standard antiviral pills. The goal was to see if the vaccine could further reduce virus levels and improve the immune response. The t…

This early-stage study tested a new drug called GSK3965193, alone or with another drug (bepirovirsen), in healthy volunteers and people with chronic hepatitis B. The goal was to check safety and whether the drug could lower hepatitis B virus levels. The study was terminated early…

This early-phase study tested a combination of two drugs (niraparib and dostarlimab) in 47 children and teens with solid tumors that had come back or not responded to treatment. The goal was to find the safest dose and see if the drugs could shrink tumors. The study was terminate…

This early-stage study tested a single dose of an experimental drug called GSK4172239D in 11 adults with sickle cell disease. The goal was to check safety and how the drug moves through the body. The study was terminated early, so results are limited.

This study tested the long-term safety of an experimental drug called GSK1070806 in adults with moderate to severe atopic dermatitis (eczema). It was designed for people who had already completed an earlier study of the same drug. The study was terminated early, so only limited s…

This study tested an experimental drug called GSK3858279 to see if it could reduce moderate to severe knee pain from osteoarthritis. About 314 adults aged 40 to 80 took part. The trial was stopped early, so we don't have final results on how well the drug worked or its safety.

This study tested an experimental drug called GSK3858279 in 147 adults with long-term nerve pain caused by diabetes. The goal was to see if the drug could reduce pain better than a placebo. The trial was stopped early, so final results are limited, but the data may still help res…

This was the first study to give GSK3494245 to humans, testing its safety and how the body handles it. 59 healthy adults received up to three single doses of the drug or a placebo. The study was terminated early, so results are limited.